Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 70% · prior close shown (market closed)
Nanobiotix S.A. shows accelerating business momentum based on AlphaOS pipeline evidence, with mixed management execution.
Why it matters: Revenue +355% YoY in Q4 FY2025.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 28d ago
Reported figures for Nanobiotix S.A. — research only, not investment advice.
Updated
What happened recently for Nanobiotix S.A. (NBTX) — events, not interpretation.
Research & analysis only — not investment advice.
Prior close
$38.31
Market cap
$1.85B
Profitable
No
Revenue $29.64M
Net income
$-23.96M
FY Jul 22, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Nanobiotix S.A. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Structured stock intelligence for companies connected to this research.
Follow Nanobiotix S.A. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.